• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症中心血管诊断与长期确诊残疾进展的共病发作:一项为期 15 年的随访研究。

Comorbid onset of cardiovascular diagnosis and long-term confirmed disability progression in multiple sclerosis: A 15-year follow-up study.

机构信息

Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.

Jacobs Comprehensive MS Treatment and Research Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.

出版信息

J Neurol Sci. 2024 Sep 15;464:123156. doi: 10.1016/j.jns.2024.123156. Epub 2024 Jul 29.

DOI:10.1016/j.jns.2024.123156
PMID:39096837
Abstract

BACKGROUND

People with multiple sclerosis (pwMS) have greater prevalence of comorbid cardiovascular diseases (CVD) when compared to the general population despite similar frequency of CV risk factors.

OBJECTIVE

Determine the impact of comorbid-onset of CVD diagnosis on long-term confirmed disability progression (CDP).

METHODS

276 pwMS (29 clinically isolated syndrome, 130 relapsing-remitting and 117 progressive) were clinically followed an average of 14.9 years, with a mean of 14.4 clinical visits. Retrospective electronic medical records (EMR) review determined CVD diagnoses (hypertension, hyperlipidemia, diabetes, and heart disease) at baseline and over the follow-up. CDP was determined with ≥1.0 point Expanded Disability Status Scale (EDSS) increase from EDSS <5.5, or ≥ 0.5-point increase from ≥5.5, and was sustained on next clinical visit.

RESULTS

A significantly shorter time to overall CDP was detected in 213 pwMS who had an existing (28 pwMS) or developed new onset (185 pwMS) of CVD, compared to 63 CVD-healthy pwMS over the follow-up (13.4 vs 15.9 years, Mantel-Cox p < 0.001), independent of baseline age and EDSS score. The CVD diagnosis preceded the CDP in 103 pwMS (55.7%), occurred after CDP in 71 pwMS (38.4%) and was concurrent in 11 pwMS (5.9%). Using mixed-effect models adjusted for significant age (F = 56.5, p < 0.001) and time effects (F = 67.8, p < 0.001), the CVD-onset diagnosis was associated with greater accrual of disability, as measured by longitudinal increase in EDSS score (F = 4.207, p = 0.04). Sex was not significant predictor of future disability in our cohort.

CONCLUSION

PwMS with an existing or new onset of comorbid CVD diagnosis showed accelerated disability worsening over long-term. There was no temporal relationship between the onset of CVD and CDP within the group that had CVD-onset diagnosis.

摘要

背景

与普通人群相比,多发性硬化症(MS)患者尽管心血管风险因素的频率相似,但合并心血管疾病(CVD)的患病率更高。

目的

确定合并 CVD 诊断对长期确诊残疾进展(CDP)的影响。

方法

276 名 MS 患者(29 例临床孤立综合征、130 例复发缓解型和 117 例进展型)平均临床随访 14.9 年,平均随访 14.4 次。回顾性电子病历(EMR)回顾确定基线和随访期间的 CVD 诊断(高血压、高脂血症、糖尿病和心脏病)。CDP 通过扩展残疾状况量表(EDSS)≥1.0 点从 EDSS <5.5 增加或从≥5.5 增加≥0.5 点确定,并在下一次临床就诊时持续存在。

结果

在 213 名患有合并 CVD(28 名 MS 患者)或新发 CVD(185 名 MS 患者)的 MS 患者中,与 63 名 CVD 健康的 MS 患者相比,整体 CDP 的时间明显缩短,在随访过程中(13.4 岁 vs 15.9 岁,Mantel-Cox p <0.001),与基线年龄和 EDSS 评分无关。在 103 名 MS 患者(55.7%)中,CVD 诊断先于 CDP,在 71 名 MS 患者(38.4%)中,CVD 诊断晚于 CDP,在 11 名 MS 患者(5.9%)中,CVD 诊断与 CDP 同时发生。使用调整了显著年龄(F = 56.5,p <0.001)和时间效应(F = 67.8,p <0.001)的混合效应模型,CVD 发病诊断与残疾的累积程度有关,表现为 EDSS 评分的纵向增加(F = 4.207,p = 0.04)。在我们的队列中,性别并不是未来残疾的显著预测因素。

结论

患有合并 CVD 诊断的 MS 患者在长期随访中显示出残疾恶化加速。在患有 CVD 发病诊断的组中,CVD 发病与 CDP 之间没有时间关系。

相似文献

1
Comorbid onset of cardiovascular diagnosis and long-term confirmed disability progression in multiple sclerosis: A 15-year follow-up study.多发性硬化症中心血管诊断与长期确诊残疾进展的共病发作:一项为期 15 年的随访研究。
J Neurol Sci. 2024 Sep 15;464:123156. doi: 10.1016/j.jns.2024.123156. Epub 2024 Jul 29.
2
Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium.疾病修正治疗、长期预后与进展性多发性硬化的转化:基于纽约州多发性硬化协会的数据。
J Neurol. 2024 Feb;271(2):711-722. doi: 10.1007/s00415-023-12099-x. Epub 2023 Nov 23.
3
Impact of comorbidities on the disability progression in multiple sclerosis.合并症对多发性硬化症残疾进展的影响。
Acta Neurol Scand. 2022 Jan;145(1):24-29. doi: 10.1111/ane.13516. Epub 2021 Aug 20.
4
Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis.频域光学相干断层扫描与多发性硬化症长期残疾恶化的关联
Neurology. 2021 Apr 20;96(16):e2058-e2069. doi: 10.1212/WNL.0000000000011788. Epub 2021 Mar 2.
5
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.疾病修正药物可降低复发型多发性硬化的残疾进展。
Brain. 2020 Oct 1;143(10):3013-3024. doi: 10.1093/brain/awaa251.
6
Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: A retrospective analysis from the CombiRx trial.复发缓解型多发性硬化症小脑病变与残疾恶化:来自 CombiRx 试验的回顾性分析。
Eur J Neurol. 2022 Feb;29(2):515-521. doi: 10.1111/ene.15157. Epub 2021 Nov 17.
7
Information processing speed as a prognostic marker of physical impairment and progression in patients with multiple sclerosis.信息处理速度作为多发性硬化症患者身体损伤和进展的预后标志物。
Mult Scler Relat Disord. 2022 Jan;57:103353. doi: 10.1016/j.msard.2021.103353. Epub 2021 Oct 29.
8
Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.儿童发病多发性硬化症患者延迟治疗对残疾的长期影响:一项前瞻性丹麦队列研究。
Mult Scler Relat Disord. 2020 May;40:101956. doi: 10.1016/j.msard.2020.101956. Epub 2020 Jan 17.
9
Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis.利妥昔单抗治疗与继发进展型多发性硬化症患者残疾进展的关联。
JAMA Neurol. 2019 Mar 1;76(3):274-281. doi: 10.1001/jamaneurol.2018.4239.
10
Assessment of T2 lesion-based disease activity volume outcomes in predicting disease progression in multiple sclerosis over 10 years.评估 T2 病变为基础的疾病活动体积结局在预测多发性硬化症 10 年内疾病进展中的作用。
Mult Scler Relat Disord. 2022 Nov;67:104187. doi: 10.1016/j.msard.2022.104187. Epub 2022 Sep 18.

引用本文的文献

1
Advanced multiple sclerosis: an exploratory study on a neglected patient population.进展型多发性硬化症:对一个被忽视患者群体的探索性研究。
J Neurol. 2025 Aug 3;272(8):553. doi: 10.1007/s00415-025-13296-6.